Spectrum Pharmaceuticals reported $185K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Actinium Pharmaceuticals ATNM:US $ 22K 0
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Arrowhead Research ARWR:US $ 198K 0
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 387M 0M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Coherus Biosciences CHRS:US $ 0.01M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Mirati Therapeutics MRTX:US $ 0.06M 0M
Novartis NOVN:VX SF 890M 11M
Puma Biotechnology PBYI:US $ 0M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.18M 0.01M
Takeda 4502:JP Y 1676277M 14M
Teva Pharmaceutical TEVA:IT 57M 0
YTE INCY:US $ 0.22M 0M